Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family

Shiliang Wu

doi:doi:10.11648/j.abb.20210901.13

| Peer-Reviewed

Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family

Shiliang Wu

Published in Advances in Bioscience and Bioengineering (Volume 9, Issue 1)

Received: 16 March 2021 Accepted: 30 March 2021 Published: 12 April 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Insights into binding mechanism of inhibitors to targets are expected to provide a meaningfully theoretical guidance for design and development of effective inhibitors inhibiting of the activity of targets. It is well known that the bromodomain (BRD) family has been thought as a promising target utilized for treating various human diseases, such as inflammatory disorders, malignant tumors, acute myelogenous leukemia (AML), bone diseases, etc. In this work, we summarize the roles of integration of multiple simulation technologies in exploring atomic-level dynamics changes of the BRD family because of inhibitor bindings. Molecular dynamics (MD) simulations, binding free energy calculations, calculations of dynamics cross-correlation maps (DCCMs), and principal component (PC) analysis are integrated together to uncover binding modes of inhibitors to BRDs. The results obtained from binding free energy calculations can measure binding ability of inhibitors to BRDs, and explore the main driving forces of the binding of inhibitors to BRDs. The information stemming from PC analysis can reveal the changes in conformations, internal dynamics and movement patterns of BRDs due to inhibitor associations. Residue-based free energy decomposition method is wielded to unveil contributions of separate residues to inhibitor bindings, and explore the decisive factors that affect the bindings of inhibitors to BRDs.

Published in	Advances in Bioscience and Bioengineering (Volume 9, Issue 1)
DOI	10.11648/j.abb.20210901.13
Page(s)	13-19
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Molecular Dynamics Simulations, Principal Component Analysis, MM-GBSA

References

[1]	L. Wang, Y. Wang, H. Sun, J. Zhao, Q. Wang, Theoretical insight into molecular mechanisms of inhibitor bindings to bromodomain-containing protein 4 using molecular dynamics simulations and calculations of binding free energies, Chem. Phys. Lett. 736 (2019) 136785.
[2]	J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, J. Chen, Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations, Chem. Biol. Drug. Des. 93 (2019) 163-176.
[3]	W. L. DeLano, The PyMOL molecular graphics system, Available at http://www.pymol.org.
[4]	D. S. Goodsell, G. M. Morris, A. J. Olson, Automated docking of flexible ligands: applications of AutoDock, J. Mol. Recognit. 9 (1996) 1-5.
[5]	D. A. Case, T. E. Cheatham, 3rd, T. Darden, H. Gohlke, R. Luo, K. M. Merz, Jr., A. Onufriev, C. Simmerling, B. Wang, R. J. Woods, The Amber biomolecular simulation programs, J. Comput. Chem. 26 (2005) 1668-1688.
[6]	H. Li, A. D. Robertson, J. H. Jensen, Very fast empirical prediction and rationalization of protein pKa values, Proteins 61 (2005) 704-721.
[7]	J. Wang, R. M. Wolf, J. W. Caldwell, P. A. Kollman, D. A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004) 1157-1174.
[8]	J. A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K. E. Hauser, C. Simmerling, ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB, J. Chem. Theory Comput. 11 (2015) 3696-3713.
[9]	W. L. Jorgensen, J. Chandrasekhar, J. D. Madura, R. W. Impey, M. L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983) 926-935.
[10]	A. Jakalian, D. B. Jack, C. I. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation, J. Comput. Chem. 23 (2002) 1623-1641.
[11]	R. Salomon-Ferrer, A. W. Götz, D. Poole, S. Le Grand, R. C. Walker, Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald, J. Chem. Theory Comput. 9 (2013) 3878-3888.
[12]	J. Chen, X. Wang, T. Zhu, Q. Zhang, J. Z. H. Zhang, A Comparative Insight into Amprenavir Resistance of Mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 Protease Based on Thermodynamic Integration and MM-PBSA Methods, J. Chem. Inf. Model. 55 (2015) 1903-1913.
[13]	J. Chen, X. Wang, L. Pang, J. Z. H. Zhang, T. Zhu, Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations, Nucleic Acids Res. 47 (2019) 6618-6631. doi: 10.1093/nar/gkz499.
[14]	T. G. Coleman, H. C. Mesick, R. L. Darby, Numerical integration: a method for improving solution stability in models of the circulation, Ann Biomed. Eng. 5 (1977) 322-328.
[15]	U. Essmann, L. Perera, M. L. Berkowitz, T. Darden, H. Lee, L. G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995) 8577-8593.
[16]	J. A. Izaguirre, D. P. Catarello, J. M. Wozniak, R. D. Skeel, Langevin stabilization of molecular dynamics, J. Chem. Phys. 114 (2001) 2090-2098.
[17]	J. Chen, X. Liu, S. Zhang, J. Chen, H. Sun, L. Zhang, Q. Zhang, Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses, Phys. Chem. Chem. Phys. 22 (2020) 2262-2275.
[18]	P. Auffinger, E. Westhof, RNA hydration: three nanoseconds of multiple molecular dynamics simulations of the solvated tRNA (Asp) anticodon hairpin, J. Mol. Biol. 269 (1997) 326-341.
[19]	L. S. Caves, J. D. Evanseck, M. Karplus, Locally accessible conformations of proteins: multiple molecular dynamics simulations of crambin, Protein Sci. 7 (1998) 649-666.
[20]	J. Chen, J. Wang, B. Yin, L. Pang, W. Wang, W. Zhu, Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions, ACS Chem. Neurosci. 10 (2019) 4303-4318.
[21]	S. Tian, J. Zeng, X. Liu, J. Chen, J. Z. H. Zhang, T. Zhu, Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling, Phys. Chem. Chem. Phys. 21 (2019) 22103-22112.
[22]	T. Ichiye, M. Karplus, Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations, Proteins 11 (1991) 205-217.
[23]	J. Chen, W. Wang, L. Pang, W. Zhu, Unveiling conformational dynamics changes of H-Ras induced by mutations based on accelerated molecular dynamics, Phys. Chem. Chem. Phys. 22 (2020) 21238-21250.
[24]	R. M. Levy, A. R. Srinivasan, W. K. Olson, J. A. McCammon, Quasi-harmonic method for studying very low frequency modes in proteins, Biopolymers 23 (1984) 1099-1112.
[25]	J. Chen, B. Yin, W. Wang, H. Sun, Effects of Disulfide Bonds on Binding of Inhibitors to β-Amyloid Cleaving Enzyme 1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations, ACS Chem. Neurosci. 11 (2020) 1811-1826.
[26]	J. Chen, J. Wang, F. Lai, W. Wang, L. Pang, W. Zhu, Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations, RSC Adv. 8 (2018) 25456-25467.
[27]	D. R. Roe, T. E. Cheatham, 3rd, PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data, J. Chem. Theory Comput. 9 (2013) 3084-3095.
[28]	A. D. McLachlan, Gene duplications in the structural evolution of chymotrypsin, J. Mol. Biol. 128 (1979) 49-79.
[29]	A. Amadei, A. B. M. Linssen, H. J. C. Berendsen, Essential dynamics of proteins, Proteins: Structure, Function, and Bioinformatics 17 (1993) 412-425.
[30]	W. Wang, P. A. Kollman, Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance, Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14937-14942.
[31]	J. Wang, P. Morin, W. Wang, P. A. Kollman, Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA, J. Am. Chem. Soc. 123 (2001) 5221-5230.
[32]	J. Chen, W. Wang, H. Sun, L. Pang, B. Yin, Mutation-mediated influences on binding of anaplastic lymphoma kinase to crizotinib decoded by multiple replica Gaussian accelerated molecular dynamics, J. Comput. Aid. Mol. Des. 34 (2020) 1289-1305.
[33]	S. L. Wu, L. F. Wang, H. B. Sun, W. Wang, Y. X. Yu, Probing molecular mechanism of inhibitor bindings to bromodomain-containing protein 4 based on molecular dynamics simulations and principal component analysis, SAR QSAR Environ. Res. 31 (2020) 547-570.
[34]	F. Yan, X. Liu, S. Zhang, J. Su, Q. Zhang, J. Chen, Effect of double mutations T790M/L858R on conformation and drug-resistant mechanism of epidermal growth factor receptor explored by molecular dynamics simulations, RSC Adv. 8 (2018) 39797-39810.
[35]	T. Hou, J. Wang, Y. Li, W. Wang, Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations, J. Chem. Inf. Model. 51 (2011) 69-82.
[36]	H. Sun, Y. Li, S. Tian, L. Xu, T. Hou, Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set, Phys. Chem. Chem. Phys. 16 (2014) 16719-16729.
[37]	M. Naïm, S. Bhat, K. N. Rankin, S. Dennis, S. F. Chowdhury, I. Siddiqi, P. Drabik, T. Sulea, C. I. Bayly, A. Jakalian, E. O. Purisima, Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space, J. Chem. Inf. Model. 47 (2007) 122-133.
[38]	J. Chen, J. Wang, W. Zhu, Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation, PLoS One 9 (2014) e99862.
[39]	J. Zhu, J. Dong, L. Batiste, A. Unzue, A. Dolbois, V. Pascanu, P. Śledź, C. Nevado, A. Caflisch, Binding Motifs in the CBP Bromodomain: An Analysis of 20 Crystal Structures of Complexes with Small Molecules, ACS Med. Chem. Lett. 9 (2018) 929-934.

Cite This Article

Plain Text BibTeX RIS

APA Style

Shiliang Wu. (2021). Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family. Advances in Bioscience and Bioengineering, 9(1), 13-19. https://doi.org/10.11648/j.abb.20210901.13

Copy | Download

ACS Style

Shiliang Wu. Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family. Adv. BioSci. Bioeng. 2021, 9(1), 13-19. doi: 10.11648/j.abb.20210901.13

Copy | Download

AMA Style

Shiliang Wu. Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family. Adv BioSci Bioeng. 2021;9(1):13-19. doi: 10.11648/j.abb.20210901.13

Copy | Download

@article{10.11648/j.abb.20210901.13,
  author = {Shiliang Wu},
  title = {Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family},
  journal = {Advances in Bioscience and Bioengineering},
  volume = {9},
  number = {1},
  pages = {13-19},
  doi = {10.11648/j.abb.20210901.13},
  url = {https://doi.org/10.11648/j.abb.20210901.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20210901.13},
  abstract = {Insights into binding mechanism of inhibitors to targets are expected to provide a meaningfully theoretical guidance for design and development of effective inhibitors inhibiting of the activity of targets. It is well known that the bromodomain (BRD) family has been thought as a promising target utilized for treating various human diseases, such as inflammatory disorders, malignant tumors, acute myelogenous leukemia (AML), bone diseases, etc. In this work, we summarize the roles of integration of multiple simulation technologies in exploring atomic-level dynamics changes of the BRD family because of inhibitor bindings. Molecular dynamics (MD) simulations, binding free energy calculations, calculations of dynamics cross-correlation maps (DCCMs), and principal component (PC) analysis are integrated together to uncover binding modes of inhibitors to BRDs. The results obtained from binding free energy calculations can measure binding ability of inhibitors to BRDs, and explore the main driving forces of the binding of inhibitors to BRDs. The information stemming from PC analysis can reveal the changes in conformations, internal dynamics and movement patterns of BRDs due to inhibitor associations. Residue-based free energy decomposition method is wielded to unveil contributions of separate residues to inhibitor bindings, and explore the decisive factors that affect the bindings of inhibitors to BRDs.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family
AU  - Shiliang Wu
Y1  - 2021/04/12
PY  - 2021
N1  - https://doi.org/10.11648/j.abb.20210901.13
DO  - 10.11648/j.abb.20210901.13
T2  - Advances in Bioscience and Bioengineering
JF  - Advances in Bioscience and Bioengineering
JO  - Advances in Bioscience and Bioengineering
SP  - 13
EP  - 19
PB  - Science Publishing Group
SN  - 2330-4162
UR  - https://doi.org/10.11648/j.abb.20210901.13
AB  - Insights into binding mechanism of inhibitors to targets are expected to provide a meaningfully theoretical guidance for design and development of effective inhibitors inhibiting of the activity of targets. It is well known that the bromodomain (BRD) family has been thought as a promising target utilized for treating various human diseases, such as inflammatory disorders, malignant tumors, acute myelogenous leukemia (AML), bone diseases, etc. In this work, we summarize the roles of integration of multiple simulation technologies in exploring atomic-level dynamics changes of the BRD family because of inhibitor bindings. Molecular dynamics (MD) simulations, binding free energy calculations, calculations of dynamics cross-correlation maps (DCCMs), and principal component (PC) analysis are integrated together to uncover binding modes of inhibitors to BRDs. The results obtained from binding free energy calculations can measure binding ability of inhibitors to BRDs, and explore the main driving forces of the binding of inhibitors to BRDs. The information stemming from PC analysis can reveal the changes in conformations, internal dynamics and movement patterns of BRDs due to inhibitor associations. Residue-based free energy decomposition method is wielded to unveil contributions of separate residues to inhibitor bindings, and explore the decisive factors that affect the bindings of inhibitors to BRDs.
VL  - 9
IS  - 1
ER  -

Copy | Download

Author Information

Shiliang Wu

School of Science, Shandong Jiaotong University, Jinan, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Shiliang Wu. (2021). Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family. Advances in Bioscience and Bioengineering, 9(1), 13-19. https://doi.org/10.11648/j.abb.20210901.13

Copy | Download

ACS Style

Shiliang Wu. Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family. Adv. BioSci. Bioeng. 2021, 9(1), 13-19. doi: 10.11648/j.abb.20210901.13

Copy | Download

AMA Style

Shiliang Wu. Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family. Adv BioSci Bioeng. 2021;9(1):13-19. doi: 10.11648/j.abb.20210901.13

Copy | Download

@article{10.11648/j.abb.20210901.13,
  author = {Shiliang Wu},
  title = {Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family},
  journal = {Advances in Bioscience and Bioengineering},
  volume = {9},
  number = {1},
  pages = {13-19},
  doi = {10.11648/j.abb.20210901.13},
  url = {https://doi.org/10.11648/j.abb.20210901.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20210901.13},
  abstract = {Insights into binding mechanism of inhibitors to targets are expected to provide a meaningfully theoretical guidance for design and development of effective inhibitors inhibiting of the activity of targets. It is well known that the bromodomain (BRD) family has been thought as a promising target utilized for treating various human diseases, such as inflammatory disorders, malignant tumors, acute myelogenous leukemia (AML), bone diseases, etc. In this work, we summarize the roles of integration of multiple simulation technologies in exploring atomic-level dynamics changes of the BRD family because of inhibitor bindings. Molecular dynamics (MD) simulations, binding free energy calculations, calculations of dynamics cross-correlation maps (DCCMs), and principal component (PC) analysis are integrated together to uncover binding modes of inhibitors to BRDs. The results obtained from binding free energy calculations can measure binding ability of inhibitors to BRDs, and explore the main driving forces of the binding of inhibitors to BRDs. The information stemming from PC analysis can reveal the changes in conformations, internal dynamics and movement patterns of BRDs due to inhibitor associations. Residue-based free energy decomposition method is wielded to unveil contributions of separate residues to inhibitor bindings, and explore the decisive factors that affect the bindings of inhibitors to BRDs.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Roles of Integration of Multiple Simulation Technologies in Insights into Binding Mechanism of Inhibitors to BRD Family
AU  - Shiliang Wu
Y1  - 2021/04/12
PY  - 2021
N1  - https://doi.org/10.11648/j.abb.20210901.13
DO  - 10.11648/j.abb.20210901.13
T2  - Advances in Bioscience and Bioengineering
JF  - Advances in Bioscience and Bioengineering
JO  - Advances in Bioscience and Bioengineering
SP  - 13
EP  - 19
PB  - Science Publishing Group
SN  - 2330-4162
UR  - https://doi.org/10.11648/j.abb.20210901.13
AB  - Insights into binding mechanism of inhibitors to targets are expected to provide a meaningfully theoretical guidance for design and development of effective inhibitors inhibiting of the activity of targets. It is well known that the bromodomain (BRD) family has been thought as a promising target utilized for treating various human diseases, such as inflammatory disorders, malignant tumors, acute myelogenous leukemia (AML), bone diseases, etc. In this work, we summarize the roles of integration of multiple simulation technologies in exploring atomic-level dynamics changes of the BRD family because of inhibitor bindings. Molecular dynamics (MD) simulations, binding free energy calculations, calculations of dynamics cross-correlation maps (DCCMs), and principal component (PC) analysis are integrated together to uncover binding modes of inhibitors to BRDs. The results obtained from binding free energy calculations can measure binding ability of inhibitors to BRDs, and explore the main driving forces of the binding of inhibitors to BRDs. The information stemming from PC analysis can reveal the changes in conformations, internal dynamics and movement patterns of BRDs due to inhibitor associations. Residue-based free energy decomposition method is wielded to unveil contributions of separate residues to inhibitor bindings, and explore the decisive factors that affect the bindings of inhibitors to BRDs.
VL  - 9
IS  - 1
ER  -

Copy | Download